FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3119393886> ?p ?o ?g. }

• W3119393886 endingPage "109370" @default.
• W3119393886 startingPage "109370" @default.
• W3119393886 abstract "The aberrant expression level of SARS-CoV-2 cell receptor gene ACE2 was reported in lung adenocarcinoma (LUAD) comorbidity of COVID-19. However, the association of ACE2 expression levels with immunosuppression and metabolic reprogramming in LUAD remains lacking. We investigated the expression level of ACE2, an association of ACE2 expression level with various types of immune signatures, immune ratios, and pathways. We employed a weighted gene co-expression network analysis (WGCNA) R package to identify the gene modules and investigated prognostic roles of hub genes in LUAD. Overexpression of ACE2 level was found in LUAD and ACE2 expression was negatively associated with various types of immune signatures including CD8+ T cells, CD4+ regulatory T cells, NK cells, and T cell activation. Besides, ACE2 upregulation was not only associated with CD8+ T cell/CD4+ regulatory T cell ratios but also linked with downregulation of immune-markers including CD8A, KLRC1, GZMA, GZMB, NKG7, CCL4, and IFNG. Moreover, the ACE2 expression level was found to be associated with the enrichment level of various metabolic pathways and it was also found that the metabolic pathways are directly positively correlated with the increased expression levels of ACE2, indicating that the overexpression of ACE2 is associated with metabolic reprogramming in LUAD. Furthermore, WGCNA based analysis revealed the gene modules in the high-ACE2-expression-level group of LUAD and identified GCLC and SLC7A11 hub genes which are not only highly expressed in lung adenocarcinoma but also correlated with the poor survival prognosis. Our analysis of ACE2 in LUAD tissues suggests that ACE2 is not only a receptor but is also associated with immunosuppression and metabolic reprogramming. This study underlines the clue for understanding the clinical significance of ACE2 in COVID-19 patients with LUAD comorbidity." @default.
• W3119393886 created "2021-01-18" @default.
• W3119393886 creator A5007135505 @default.
• W3119393886 creator A5037387198 @default.
• W3119393886 creator A5050182962 @default.
• W3119393886 creator A5060588206 @default.
• W3119393886 date "2021-02-01" @default.
• W3119393886 modified "2023-10-16" @default.
• W3119393886 title "Expression of SARS-COV-2 cell receptor gene ACE2 is associated with immunosuppression and metabolic reprogramming in lung adenocarcinoma based on bioinformatics analyses of gene expression profiles" @default.
• W3119393886 cites W1566831845 @default.
• W3119393886 cites W1966238900 @default.
• W3119393886 cites W1966327575 @default.
• W3119393886 cites W1971096486 @default.
• W3119393886 cites W1976319679 @default.
• W3119393886 cites W1977406426 @default.
• W3119393886 cites W1992137695 @default.
• W3119393886 cites W2009242103 @default.
• W3119393886 cites W2018838463 @default.
• W3119393886 cites W2029349480 @default.
• W3119393886 cites W2035618305 @default.
• W3119393886 cites W2040876125 @default.
• W3119393886 cites W2048000549 @default.
• W3119393886 cites W2072974730 @default.
• W3119393886 cites W2077623174 @default.
• W3119393886 cites W2106747061 @default.
• W3119393886 cites W2117692326 @default.
• W3119393886 cites W2118423420 @default.
• W3119393886 cites W2123106337 @default.
• W3119393886 cites W2130410032 @default.
• W3119393886 cites W2131967412 @default.
• W3119393886 cites W2137761597 @default.
• W3119393886 cites W2159707944 @default.
• W3119393886 cites W2180481128 @default.
• W3119393886 cites W2223535266 @default.
• W3119393886 cites W2234115940 @default.
• W3119393886 cites W2410336499 @default.
• W3119393886 cites W2559588208 @default.
• W3119393886 cites W2566944468 @default.
• W3119393886 cites W2607129810 @default.
• W3119393886 cites W2611596972 @default.
• W3119393886 cites W2791106616 @default.
• W3119393886 cites W2796084557 @default.
• W3119393886 cites W2804040141 @default.
• W3119393886 cites W2889646458 @default.
• W3119393886 cites W2900569176 @default.
• W3119393886 cites W2907559247 @default.
• W3119393886 cites W2912285735 @default.
• W3119393886 cites W2919023968 @default.
• W3119393886 cites W2921012064 @default.
• W3119393886 cites W2977153113 @default.
• W3119393886 cites W2982872965 @default.
• W3119393886 cites W2992324722 @default.
• W3119393886 cites W3003382674 @default.
• W3119393886 cites W3004280078 @default.
• W3119393886 cites W3004318991 @default.
• W3119393886 cites W3006355661 @default.
• W3119393886 cites W3013125498 @default.
• W3119393886 cites W3020098446 @default.
• W3119393886 cites W3022550650 @default.
• W3119393886 cites W3023991776 @default.
• W3119393886 cites W3028561150 @default.
• W3119393886 cites W3030573714 @default.
• W3119393886 cites W3044275121 @default.
• W3119393886 cites W3045774637 @default.
• W3119393886 cites W3083791147 @default.
• W3119393886 doi "https://doi.org/10.1016/j.cbi.2021.109370" @default.
• W3119393886 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7833036" @default.
• W3119393886 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33422520" @default.
• W3119393886 hasPublicationYear "2021" @default.
• W3119393886 type Work @default.
• W3119393886 sameAs 3119393886 @default.
• W3119393886 citedByCount "8" @default.
• W3119393886 countsByYear W31193938862021 @default.
• W3119393886 countsByYear W31193938862022 @default.
• W3119393886 countsByYear W31193938862023 @default.
• W3119393886 crossrefType "journal-article" @default.
• W3119393886 hasAuthorship W3119393886A5007135505 @default.
• W3119393886 hasAuthorship W3119393886A5037387198 @default.
• W3119393886 hasAuthorship W3119393886A5050182962 @default.
• W3119393886 hasAuthorship W3119393886A5060588206 @default.
• W3119393886 hasBestOaLocation W31193938861 @default.
• W3119393886 hasConcept C104317684 @default.
• W3119393886 hasConcept C121608353 @default.
• W3119393886 hasConcept C127561419 @default.
• W3119393886 hasConcept C150194340 @default.
• W3119393886 hasConcept C162317418 @default.
• W3119393886 hasConcept C167672396 @default.
• W3119393886 hasConcept C203014093 @default.
• W3119393886 hasConcept C2781182431 @default.
• W3119393886 hasConcept C502942594 @default.
• W3119393886 hasConcept C54355233 @default.
• W3119393886 hasConcept C77255625 @default.
• W3119393886 hasConcept C86803240 @default.
• W3119393886 hasConcept C8891405 @default.
• W3119393886 hasConceptScore W3119393886C104317684 @default.
• W3119393886 hasConceptScore W3119393886C121608353 @default.
• W3119393886 hasConceptScore W3119393886C127561419 @default.
• W3119393886 hasConceptScore W3119393886C150194340 @default.

• next